HHM Wealth Advisors’s VanEck Pharmaceutical ETF PPH Stock Holding History

HHM Wealth Advisors’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$148K	Hold	1,350	–	–	0.01%	241
2026 Q1	$140K	Hold	1,350	–	–	0.02%	225
2025 Q4	$139K	Hold	1,350	–	–	0.02%	229
2025 Q3	$122K	Hold	1,350	–	–	0.01%	259
2025 Q2	$119K	Hold	1,350	–	–	0.01%	258
2025 Q1	$123K	Buy	+1,350	New	+$122K	0.02%	242

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

HHM Wealth Advisors's PPH Position: Q2 2026 in Review

HHM Wealth Advisors held its VanEck Pharmaceutical ETF (PPH) position steady in Q2 2026 at 1,350 shares worth $148K. The position accounts for 0.01% of the portfolio, ranked #241.

HHM Wealth Advisors first reported a position in PPH in Q1 2025 and has held it in 6 quarters since. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

HHM Wealth Advisors held 1,350 shares of VanEck Pharmaceutical ETF worth $148K as of Q2 2026.
HHM Wealth Advisors left its VanEck Pharmaceutical ETF share count unchanged in Q2 2026.
VanEck Pharmaceutical ETF made up 0.01% of HHM Wealth Advisors's portfolio in Q2 2026, its #241 holding.
HHM Wealth Advisors first reported a position in VanEck Pharmaceutical ETF in Q1 2025 and has held it in 6 quarters since.
148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on HHM Wealth Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.